BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Ridge Diagnostics, Inc. CEO to Speak at Neurotech Investing and Partnering Conference


5/5/2011 8:01:12 AM

SAN DIEGO, May 5, 2011 /PRNewswire/ -- Ridge Diagnostics, Inc., a neurodiagnostic company, announced that Lonna J. Williams, CEO will speak at the 6th Annual Neurotech Investing and Partnering Conference to be held in San Francisco, CA at the St. Regis Hotel on May 9th and 10th.

Ms. Williams, a clinical diagnostics industry veteran, will participate on a panel entitled "Next Generation Psychiatry" lead by Dr. Manuel Lopez-Figueroa, Vice President, Bay City Capital. The panel will discuss the most promising next generation diagnostics, devices and treatments for neuropsychiatric disorders such as depression, schizophrenia, anxiety, addiction and others.

Ridge Diagnostics develops and sells blood tests which aid in the diagnosis and management of clinical depression or Major Depressive Disorder. For the first time, a blood test provides clinicians and patients with objective, biologically based, diagnostic information to manage and treat this disorder. Blood test results are intended to augment the current tools used for neuropsychiatric diagnosis and patient management. Additional tests are in development for antidepressant efficacy monitoring and adolescent depression.

Ridge Diagnostics, Inc. Ridge Diagnostics is a neurodiagnostic company developing and marketing blood-based tests to diagnose and monitor neuropsychiatric disorders. Ridge has commercialized the first-in-class, proprietary blood test for the diagnosis and treatment monitoring of Major Depressive Disorder (MDD). The portfolio of neurodiagnostic blood tests are based on a proprietary Human Biomarker Library and Hyper-Mapping technology. The testing services are provided by the Ridge owned CLIA laboratory. The company is located in San Diego, CA and Research Triangle Park, NC. www.ridgedx.com

Neurotech Investing and Partnering Conference. The premier partnering and investing conference where investors, executives, entrepreneurs, scientists and others involved in the development of new treatments and diagnostics for the brain and nervous system come together to shape the future of their organization and the industry. Find out about next generation drugs, devices and diagnostics for Alzheimer's, addiction, anxiety, depression, Huntington's, ALS, pain, sensory disorders, obesity, stroke, schizophrenia, sleep disorders, epilepsy, multiple sclerosis, traumatic brain injury, spinal cord injury, Parkinson's and more.

SOURCE Ridge Diagnostics, Inc.


Read at BioSpace.com


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->